USD 2.14
(-4.89%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 481.84 Thousand USD | 66.51% |
2022 | 289.37 Thousand USD | 55.97% |
2021 | 185.53 Thousand USD | -21.54% |
2020 | 236.48 Thousand USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 588.77 Thousand USD | 22.19% |
2024 Q2 | 544.76 Thousand USD | -7.47% |
2023 Q2 | 513.71 Thousand USD | 40.79% |
2023 FY | 481.84 Thousand USD | 66.51% |
2023 Q4 | 481.84 Thousand USD | -4.57% |
2023 Q3 | 504.92 Thousand USD | -1.71% |
2023 Q1 | 364.86 Thousand USD | 26.09% |
2022 Q2 | 268.33 Thousand USD | -3.75% |
2022 FY | 289.37 Thousand USD | 55.97% |
2022 Q4 | 289.37 Thousand USD | 31.35% |
2022 Q1 | 278.77 Thousand USD | 50.26% |
2022 Q3 | 220.3 Thousand USD | -17.9% |
2021 Q4 | 185.53 Thousand USD | -17.62% |
2021 Q3 | 225.21 Thousand USD | -3.77% |
2021 Q2 | 234.04 Thousand USD | -0.85% |
2021 FY | 185.53 Thousand USD | -21.54% |
2021 Q1 | 236.04 Thousand USD | -0.18% |
2020 Q3 | 86.14 Thousand USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q4 | 236.48 Thousand USD | 174.51% |
2020 FY | 236.48 Thousand USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Cosmos Health Inc. | 4.78 Million USD | 89.939% |
Safety Shot Inc | 1.86 Million USD | 74.228% |
Bright Green Corporation | - USD | -Infinity% |
Embecta Corp. | 152.1 Million USD | 99.683% |
ANI Pharmaceuticals, Inc. | 111.19 Million USD | 99.567% |
Aquestive Therapeutics, Inc. | 6.76 Million USD | 92.882% |
Collegium Pharmaceutical, Inc. | 32.33 Million USD | 98.51% |
Dynavax Technologies Corporation | 53.29 Million USD | 99.096% |
Esperion Therapeutics, Inc. | 65.62 Million USD | 99.266% |
Intra-Cellular Therapies, Inc. | 11.64 Million USD | 95.863% |
Pacira BioSciences, Inc. | 104.35 Million USD | 99.538% |
PainReform Ltd. | - USD | -Infinity% |
Sunshine Biopharma, Inc. | 5.73 Million USD | 91.598% |
Sunshine Biopharma, Inc. | 5.73 Million USD | 91.598% |
SCYNEXIS, Inc. | - USD | -Infinity% |
China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | 40.496% |
Journey Medical Corporation | 10.2 Million USD | 95.279% |
Alpha Teknova, Inc. | 11.59 Million USD | 95.844% |
Procaps Group, S.A. | 96.83 Million USD | 99.502% |
Theratechnologies Inc. | 6.06 Million USD | 92.057% |
Harrow Health, Inc. | 10.86 Million USD | 95.566% |
Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | 82.279% |
Biofrontera Inc. | 10.9 Million USD | 95.583% |
DURECT Corporation | 2.21 Million USD | 78.286% |
Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 99.378% |
Cronos Group Inc. | 30.33 Million USD | 98.412% |
OptiNose, Inc. | 8.05 Million USD | 94.016% |
Ironwood Pharmaceuticals, Inc. | 1.00 USD | -48183900.0% |
Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
RedHill Biopharma Ltd. | 5.69 Million USD | 91.545% |
Organogenesis Holdings Inc. | 28.25 Million USD | 98.295% |
Guardion Health Sciences, Inc. | 2.67 Million USD | 82.002% |
Cumberland Pharmaceuticals Inc. | 4.6 Million USD | 89.546% |
Radius Health, Inc. | 278.64 Million USD | 99.827% |
Universe Pharmaceuticals INC | 3.34 Million USD | 85.588% |
ProPhase Labs, Inc. | 3.84 Million USD | 87.455% |
Phibro Animal Health Corporation | 265.91 Million USD | 99.819% |
Procaps Group S.A. | 96.83 Million USD | 99.502% |
Alvotech | 74.43 Million USD | 99.353% |
TherapeuticsMD, Inc. | - USD | -Infinity% |
Viatris Inc. | 3.46 Billion USD | 99.986% |
Rockwell Medical, Inc. | 5.87 Million USD | 91.793% |
Aytu BioPharma, Inc. | 12.63 Million USD | 96.186% |
SIGA Technologies, Inc. | 64.21 Million USD | 99.25% |
Tilray Brands, Inc. | 252.08 Million USD | 99.809% |
Lifecore Biomedical, Inc. | 39.97 Million USD | 98.795% |
Shineco, Inc. | 1.58 Million USD | 69.667% |
PetIQ, Inc. | 159.3 Million USD | 99.698% |
Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 415.386% |
Incannex Healthcare Limited | -10.01 Million USD | 104.811% |
Neurocrine Biosciences, Inc. | 38.3 Million USD | 98.742% |
Alimera Sciences, Inc. | 1.87 Million USD | 74.357% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Assertio Holdings, Inc. | 37.68 Million USD | 98.721% |
Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
Petros Pharmaceuticals, Inc. | 1.61 Million USD | 70.079% |
Clever Leaves Holdings Inc. | 4.48 Million USD | 89.252% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -89.438% |
Avadel Pharmaceuticals plc | 10.38 Million USD | 95.358% |
Hempacco Co., Inc. | 2.54 Million USD | 81.05% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 74.43 Million USD | 99.353% |
Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 98.992% |
Lantheus Holdings, Inc. | 64.02 Million USD | 99.247% |
Currenc Group, Inc. | 732.91 Thousand USD | 34.257% |
Kamada Ltd. | 87.74 Million USD | 99.451% |
Indivior PLC | 141.79 Million USD | 99.66% |
Flora Growth Corp. | 8.5 Million USD | 94.337% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -89.438% |
Evolus, Inc. | 10.99 Million USD | 95.619% |
HUTCHMED (China) Limited | 50.25 Million USD | 99.041% |
Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 99.545% |
Akanda Corp. | 1.28 Million USD | 62.558% |